Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins

US Patent 11905525 · Granted Feb 20, 2024

Assignee

Inventors

View full patent text on Google Patents →